A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia

Ronja Bjørnstad (1, 2) , Reidun Aesoy (1) , Øystein Bruserud (1) , Annette K. Brenner (1) , Francis Giraud (3) , Tara Helen Dowling (1) , Gro Gausdal (4) , Pascale Moreau (3) , Stein Ove Døskeland (1) , Fabrice Anizon (3) , Lars Herfindal (1)

1 UiB - University of Bergen
2 Hospital Pharmacy in western Norway, Bergen
3 ICCF - Institut de Chimie de Clermont-Ferrand
4 BerGenBio AS, Bergen, Norway

Domaines: Cancer

Ronja Bjørnstad, Reidun Aesoy, Øystein Bruserud, Annette K. Brenner, Francis Giraud, et al.. A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia. Molecular Cancer Therapeutics, 2019, 18 (3), pp.567-578. ⟨10.1158/1535-7163.MCT-17-1234⟩. ⟨hal-02151102⟩